paroxysmal nonkinesigenic dyskinesia 2

MeSH: C537181ORPHA: 988101 Treatment Available

Contents

1. Overview
2. Available Treatments
3. Clinical Presentation
4. Classification & Codes

Overview

human disease

Available Treatments (1)

Drug	Form	Status	Countries	Lead Time
carbamazepine	oral tablet 200mg, 400mg; extended-release tablet; oral suspension 100mg/5mL	FDA Approved	11	7d

Clinical Presentation

Signs and symptoms associated with paroxysmal nonkinesigenic dyskinesia 2, sourced from HPO and Orphanet clinical annotations.

DystoniaParoxysmal dyskinesiaChoreoathetosisChoreaHyperkinetic movementsInvoluntary movementsTrismusTorticollisJoint stiffnessRigidityDyspneaAbnormal speech patternGeneralized muscle weaknessStaring gazeDyskinesia

Classification & Codes

MeSH Code

C537181

Orphanet Code

ORPHA:98810

paroxysmal nonkinesigenic dyskinesia 2

MeSH	`C537181`
Orphanet	`ORPHA:98810`
Treatments	1 drug(s)
Symptoms on record	15 signs
Status	published

Treatment Summary

carbamazepine

Factual Authority

Last Updated3/20/2026

Clinical DataHPO · Orphanet

Drug DataFDA · EMA · CDSCO